| abstract |
The present invention relates to a compound inducing degradation of the ceremonial protein, a method of preparing the same, and a pharmaceutical composition for the prevention or treatment of cancer containing it as an active ingredient. A novel compound represented by A-linker-A or A-linker-B, according to the present invention, can remarkably inhibit or degrade the cerebellum, and therefore, by containing it as an active ingredient, the present invention. is useful as a pharmaceutical composition for the prevention or treatment of cerebral-related diseases, preferably diseases, such as cancer, autoimmune diseases or metabolic diseases, in which effects such as treatment, prevention, or relief can be achieved by inhibition or degradation of the cerebellum. |